title: Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae.
authors.forename: Glen T
authors.initials: GT
authors.lastname: Hansen
authors.forename: Kelli
authors.initials: K
authors.lastname: Metzler
authors.forename: Karl
authors.initials: K
authors.lastname: Drlica
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Blondeau
mesh_terms: D000890:Anti-Infective Agents / Q000493:pharmacokinetics* / Q000494:pharmacology; D024841:Fluoroquinolones; D000077735:Gemifloxacin; D008826:Microbial Sensitivity Tests; D009154:Mutation; D009287:Naphthyridines / Q000493:pharmacokinetics* / Q000494:pharmacology; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; D000077735:Gemifloxacin